Rentokil Initial plc (LON:RTO – Get Free Report) insider Brian Baldwin bought 7,500,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 11th. The shares were purchased at an average cost of GBX 413 ($5.21) per share, with a total value of £30,975,000 ($39,095,039.76).
Rentokil Initial Stock Performance
Shares of LON RTO opened at GBX 413.51 ($5.22) on Friday. The company has a debt-to-equity ratio of 116.58, a current ratio of 1.04 and a quick ratio of 1.76. Rentokil Initial plc has a one year low of GBX 336.30 ($4.24) and a one year high of GBX 517.60 ($6.53). The business’s 50-day moving average price is GBX 386.78 and its two-hundred day moving average price is GBX 426.30. The company has a market capitalization of £10.38 billion, a P/E ratio of 2,584.44, a price-to-earnings-growth ratio of 0.56 and a beta of 0.55.
Analysts Set New Price Targets
Separately, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Rentokil Initial from GBX 550 ($6.94) to GBX 465 ($5.87) and set a “buy” rating on the stock in a research note on Thursday, September 12th.
About Rentokil Initial
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
See Also
- Five stocks we like better than Rentokil Initial
- Find and Profitably Trade Stocks at 52-Week Lows
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Profitably Trade Stocks at 52-Week Highs
- Texas Instruments: The Old-School Tech Titan Still Delivering
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.